The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association.

Circ Cardiovasc Genet 2017 Aug;10(4)

There have been major advances in our knowledge of the contribution of DNA sequence variations to cardiovascular disease and stroke. However, the inner workings of the body reflect the complex interplay of factors beyond the DNA sequence, including epigenetic modifications, RNA transcripts, proteins, and metabolites, which together can be considered the "expressed genome." The emergence of high-throughput technologies, including epigenomics, transcriptomics, proteomics, and metabolomics, is now making it possible to address the contributions of the expressed genome to cardiovascular disorders. This statement describes how the expressed genome can currently and, in the future, potentially be used to diagnose diseases and to predict who will develop diseases such as coronary artery disease, stroke, heart failure, and arrhythmias.

Download full-text PDF

Source
http://dx.doi.org/10.1161/HCG.0000000000000037DOI Listing
August 2017
10 Reads

Publication Analysis

Top Keywords

expressed genome
12
disease stroke
8
genome cardiovascular
8
dna sequence
8
genome" emergence
4
"expressed genome"
4
considered "expressed
4
emergence high-throughput
4
technologies including
4
transcriptomics proteomics
4
epigenomics transcriptomics
4
including epigenomics
4
metabolites considered
4
high-throughput technologies
4
transcripts proteins
4
factors dna
4
interplay factors
4
complex interplay
4
reflect complex
4
sequence including
4

References

(Supplied by CrossRef)

Musunuru K et al.
2014

Institute of Medicine et al.
2012

Similar Publications